Floatz logo

Sodium Oligomannate

Ischemic Stroke

Nanfang Hospital, Southern Medical UniversityN/AActive
D
28/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
65/ 100

Competitive context

210 Active assets in the Ischemic Stroke cohort.

Asset / SponsorPhaseRating
Ticagrelor
Sichuan Provincial People's Hospital
Phase 4BBB
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
Stanford University
Phase 4BBB
Compound Edaravone
Nanfang Hospital, Southern Medical University
Phase 4BBB
Tenecteplase
Hackensack Meridian Health
Phase 4BBB
3-N-BUTYLPHTHALIDE
Nanfang Hospital, Southern Medical University
Phase 4BBB

View all 50 →

Same molecule, other indications

Sodium Oligomannate is also rated in:

TreatmentDormant
B
Indicative ·
62 / 100
View asset →
EfficacyDormant
B
Indicative ·
62 / 100
View asset →
SafetyDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →